Website: http://www.alteritytherapeutics.com
Member Contact: Geoffrey Kempler
Position: Chairman & CEO
Industry: Biotech & Pharmaceuticals
Company Profile:
Alterity Therapeutics is developing first-in-class therapies to treat neurodegenerative diseases including its lead drug candidate, PBT434 for the treatment of Parkinsonian disorders.
Website: alteritytherapeutics.com